Table of Contents
Ulcers
Volume 2011, Article ID 391787, 5 pages
http://dx.doi.org/10.1155/2011/391787
Review Article

Cytokine Networks in Ulcerative Colitis

Department of Clinical Medicine, Gastroenterology Unit, S. Orsola-Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy

Received 15 September 2010; Accepted 27 December 2010

Academic Editor: Hiromi Sanada

Copyright © 2011 Giulia Roda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • M. S. Sajadinejad, K. Asgari, H. Molavi, M. Kalantari, and P. Adibi, “Psychological Issues in Inflammatory Bowel Disease: An Overview,” Gastroenterology Research and Practice, vol. 2012, pp. 1–11, 2012. View at Publisher · View at Google Scholar
  • Ronnell Regidor, “H2RBs vs PPIs part 2: histamine-2 receptor blockers as a first-line agent for peptic ulcer disease prophylaxis,” Gastrointestinal Nursing, vol. 11, no. 6, pp. 25–30, 2013. View at Publisher · View at Google Scholar
  • Dominique van Gent, Gareth J. Marlow, and Lynnette R. Ferguson, “Why interleukin-10 supplementation does not work in Crohn's disease patients,” World Journal Of Gastroenterology, vol. 19, no. 25, pp. 3931–3941, 2013. View at Publisher · View at Google Scholar
  • Cinthia B. B. Cazarin, Juliana K. da Silva, Talita C. Colomeu, Angela G. Batista, Conceicao A. Vilella, Anderson L. Ferreira, Stanislau Bogusz Junior, Karina Fukuda, Fabio Augusto, Luciana R. de Meirelles, Ricardo de L. Zollner, and Mario R. Marostica Junior, “Passiflora edulis peel intake and ulcerative colitis: Approaches for prevention and treatment,” Experimental Biology and Medicine, vol. 239, no. 5, pp. 542–551, 2014. View at Publisher · View at Google Scholar
  • Reynold M. Karr, “Chronic rhinosinusitis: Potential new use for topical sulfasalazine,” The Journal of Allergy and Clinical Immunology: In Practice, vol. 2, no. 3, pp. 349–350.e1, 2014. View at Publisher · View at Google Scholar
  • Sarah L. Field, Tathagata Dasgupta, Michele Cummings, Richard S. Savage, Julius Adebayo, Hema McSara, Jeremy Gunawardena, and Nicolas M. Orsi, “Bayesian modeling suggests that IL-12 (p40), IL-13 and MCP-1 drive murine cytokine networks in vivo,” BMC Systems Biology, vol. 9, no. 1, 2015. View at Publisher · View at Google Scholar
  • Qing-Kang Lv, Ju-Xiong Liu, Su-Nan Li, Ying-Jie Gao, Yan Lv, Zi-Peng Xu, Bing-Xu Huang, Shi-Yao Xu, Dong-Xue Yang, Ya-Long Zeng, Dian-Feng Liu, and Wei Wang, “Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn’s Disease Mouse Model,” International Journal of Molecular Sciences, vol. 16, no. 11, pp. 26654–26666, 2015. View at Publisher · View at Google Scholar
  • Natasa Zdravkovic, Ivan Jovanovic, Gordana Radosavljevic, Nebojsa Zdravkovic, Slobodanka Mitrovic, and Nebojsa Arsenijevic, “Potential Pro-Inflammatory Role Of VEGF In Patients With Crohn’s Disease,” Serbian Journal of Experimental and Clinical Research, vol. 16, no. 4, 2015. View at Publisher · View at Google Scholar
  • Noppawat Pengkumsri, Bhagavathi Sundaram Sivamaruthi, Sasithorn Sirilun, Sartjin Peerajan, Periyanaina Kesika, Khontaros Chaiyasut, and Chaiyavat Chaiyasut, “Extraction of β-glucan from Saccharomyces cerevisiae: Comparison of different extraction methods and in vivo assessment of immunomodulatory effect in mice,” Food Science and Technology, vol. 37, no. 1, pp. 124–130, 2016. View at Publisher · View at Google Scholar
  • Xiaohui Wei, Jane R. Kenny, Leslie Dickmann, Romeo Maciuca, Caroline Looney, and Meina T. Tang, “Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis,” The Journal of Clinical Pharmacology, vol. 56, no. 6, pp. 693–704, 2016. View at Publisher · View at Google Scholar
  • Matthew Chak Hin Szeto, Metin Devrim Yalçın, Abdul Khan, and Andrzej Piotrowicz, “Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis,” Case Reports in Immunology, vol. 2016, pp. 1–4, 2016. View at Publisher · View at Google Scholar
  • Aristeidis H. Katsanos, Kalliroi Kyriakidi, Fotini B. Karassa, Dimitrios Politis, Alexandros Skamnelos, Dimitrios K. Christodoulou, and Konstantinos H. Katsanos, “Biomarker Development in Chronic Inflammatory Diseases,” Biomarkers for Endometriosis, pp. 41–75, 2017. View at Publisher · View at Google Scholar
  • Jana Štofilová, Tomaž Langerholc, Cristian Botta, Primož Treven, Lidija Gradišnik, Rastislav Salaj, Alena Šoltésová, Izabela Bertková, Zdenka Hertelyová, and Alojz Bomba, “Cytokine production in vitro and in rat model of colitis in response to Lactobacillus plantarum LS/07,” Biomedicine & Pharmacotherapy, vol. 94, pp. 1176–1185, 2017. View at Publisher · View at Google Scholar
  • Stéphanie Da Silva, Åsa V Keita, Sofie Mohlin, Sven Påhlman, Vassilia Theodorou, Ingrid Påhlman, Jan P Mattson, and Johan D Söderholm, “A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models,” Inflammatory Bowel Diseases, 2018. View at Publisher · View at Google Scholar